# Correction: Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy

**Authors:** Michal Mego, Barbora Vlkova, Katarina Kalavska, Michal Pastorek, Zuzana Cierna, Zuzana Sestakova, Miroslav Chovanec, Natalia Udvorkova, Lucia Kucerova, Peter Celec

PMC · DOI: 10.1371/journal.pone.0340033 · PLOS One · 2025-12-31

## Full-text entities

- **Diseases:** testicular germ cell tumor (MESH:C563236)
- **Chemicals:** cisplatin (MESH:D002945)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12755787/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12755787/full.md

---
Source: https://tomesphere.com/paper/PMC12755787